We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Industry Partnerships Initiated to Fuel Neuroscience Research

By LabMedica International staff writers
Posted on 16 Nov 2014
Faster, more complex neural research is now attainable by combining technology from two research companies.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd. More...
(Nazareth, Israel) that will create a truly comprehensive set of tools for neuroscience researchers that should facilitate faster and more cost-effective research. Blackrock Microsystems will integrate specific technologies from PhenoSys and NAN Instruments to offer a fully cohesive range of electrophysiology research products.

“Our partnerships with PhenoSys and NAN instruments will fundamentally change the way neuroscientists work, so that regardless of the experiment the researcher dreams up, we can now empower them to perform it,” said Andy Gotshalk, CEO of Blackrock Microsystems. “Neuroscience research is often encumbered by mix-and-match components and complicated experiment setups. These partnerships will lessen time-consuming, expensive barriers and expedite research results so that we can achieve our ultimate objective of transferring those results into clinical practice for the millions of people facing devastating neurophysiologic challenges.”

Blackrock Microsystems’ miniaturized electrodes and amplifiers, and its data acquisition platform help researchers to perform experiments on nearly unencumbered subjects, thus yielding a clearer look into the brain's natural architecture.

PhenoSys’ technology allows researchers to construct virtual-reality mazes, where scientists can implement improvised alterations to experiments, leading to considerable cost savings of both time and money. Prior to this technology, researchers spent hours constructing physical mazes and other research environments.

“Our virtual-reality technology is already transforming neuroscience research,” said York Winter, PhD, CEO and co-founder of PhenoSys, and professor of cognitive neurobiology at Humboldt University (Berlin, Germany). “By teaming up with Blackrock Microsystems, we'll be able to help even more scientists conduct experiments that were previously thought impossible.”

NAN Instruments designs and manufactures the only electrode positioning system capable of moving individual electrodes fractions of a millimeter in a three-dimensional (3D) space. With this technology, neuroscientists can differentiate between neuron groups that were previously inseparable.

“NAN Instruments prides itself on providing flexible and reliable electrode drives,” said Nabeel Abunassar, CEO of NAN Instruments, Ltd. “Our collaboration with Blackrock Microsystems, leverages our combined strengths as leaders in the field of neuroscience research to provide integrated systems for our customers on a global scale.”

Blackrock Microsystems has become a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology has been at the center of worldwide developments in brain machine interface), implantable bionic technologies and epilepsy diagnostics.

PhenoSys is a research and development company that engineers and markets advanced technology for automated animal behavior research. The PhenoSys investigators holds extensive expertise in electrical and mechanical engineering, computer science, and behavioral biology to create experimental systems used for behavioral phenotyping, brain research, experimental psychology, and diagnostic characterization of animal models for translational medicine.

NAN Instruments designs and manufactures devices for recording electrical activity from the brain and nervous system. The unique design of the company’s electrode positioning systems provides users with effective tools that allow manipulation of each electrode individually in 3D spaces.

Related Links:

Blackrock Microsystems 
PhenoSys 
NAN Instruments



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.